Literature DB >> 19331180

Endostar induces apoptotic effects in HUVECs through activation of caspase-3 and decrease of Bcl-2.

Yun Ling1, Na Lu, Ying Gao, Yan Chen, Sen Wang, Yong Yang, Qinglong Guo.   

Abstract

BACKGROUND: Endostar is a novel recombinant human endostatin expressed and purified in Escherichia coli with the N-terminal modified. It has been shown that endostar inhibited the proliferation of human umbilical vein endothelial cells (HUVECs) through the membrane surface receptor KDR/flt-1(VEGFR-2, vascular endothelial growth factor receptor-2) by exerting anti-angiogenesis effects. But the molecular mechanism remained unclear.
MATERIALS AND METHODS: The apoptotic effects induced by endostar in the serum-deprived situation were investigated by 4'-6-diaminidino-2-phenylindole (DAPI) staining and the Annexin V-fluorescein isothiocyanate (FITC) binding assay. The mechanism of action was explored by Western blotting assay.
RESULTS: Endostar induced remarkable apoptosis in HUVECs. The expressions of apoptosis-related proteins showed that caspase-3 was activated, but caspase-8, a marker of the non-mitochondria-mediated apoptosis signal pathway, was not. Further investigation revealed that cellular Bcl-2 decreased in the endostar-treated groups, while the level of Bax was almost unchanged.
CONCLUSION: Endostar induces apoptotic effects in HUVECs through the activation of caspase-3 and a decrease of the Bcl-2 to Bax ratio.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331180

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  18 in total

1.  The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft.

Authors:  Tian-bao Wang; Xiu-qing Wei; Wei-hao Lin; Han-ping Shi; Wen-guang Dong
Journal:  Clin Exp Med       Date:  2011-06-10       Impact factor: 3.984

2.  Ultrasound-targeted cationic microbubble-mediated gene transfection and inhibition of retinal neovascularization.

Authors:  Ming-Xing Wu; Yu Zhou; Xi-Yuan Zhou; Yan Xu
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

3.  Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2.

Authors:  Reda G Yousef; Wagdy M Eldehna; Alaa Elwan; Abdelaziz S Abdelaziz; Ahmed B M Mehany; Ibraheem M M Gobaara; Bshra A Alsfouk; Eslam B Elkaeed; Ahmed M Metwaly; Ibrahim H Eissa
Journal:  Molecules       Date:  2022-06-24       Impact factor: 4.927

4.  Anti-tumor angiogenesis effect of a new compound: B-9-3 through interference with VEGFR2 signaling.

Authors:  Qin Ma; Wei Chen; Wen Chen
Journal:  Tumour Biol       Date:  2015-11-26

5.  Chrysin induces cell apoptosis via activation of the p53/Bcl-2/caspase-9 pathway in hepatocellular carcinoma cells.

Authors:  Qingyu Zhang; Sheng Ma; Bin Liu; Jie Liu; Runzhi Zhu; Mingyi Li
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

6.  Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation.

Authors:  Sanyuan Hu; Yangde Zhang
Journal:  Int J Nanomedicine       Date:  2010-11-24

7.  Comprehensive evaluation of the anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer through optical molecular imaging.

Authors:  Qian Zhang; Yang Du; Zhenwen Xue; Chongwei Chi; Xiaohua Jia; Jie Tian
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/β-catenin signaling pathway.

Authors:  Xiaoming Xu; Wei Mao; Qian Chen; Qin Zhuang; Lihui Wang; Jin Dai; Haibing Wang; Zhaoquan Huang
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

9.  Experimental endostatin-GFP gene transfection into human retinal vascular endothelial cells using ultrasound-targeted cationic microbubble destruction.

Authors:  Yan Xu; Zongyuan Xie; Yu Zhou; Xiyuan Zhou; Pan Li; Zhigang Wang; Qunxia Zhang
Journal:  Mol Vis       Date:  2015-08-25       Impact factor: 2.367

10.  Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells.

Authors:  Jie Liu; Yang Shu; Qingyu Zhang; Bin Liu; Juan Xia; Mingning Qiu; Huilai Miao; Mingyi Li; Runzhi Zhu
Journal:  Oncol Lett       Date:  2014-07-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.